Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest Adult stem cell Stories

2013-06-07 12:50:11

Through genetic engineering of laboratory models, researchers at Dartmouth-Hitchcock Norris Cotton Cancer Center have uncovered a vulnerability in the way cancer cells diverge from normal regenerating cells that may help treat children with leukemia as reported in the journal PNAS on June 3, 2013. Dartmouth researchers are trying to understand the key pathways that distinguish how a normal blood cell grows and divides compared to the altered growth that occurs in leukemia.  In addition...

2013-06-06 20:05:43

New data shows that human embryonic stem cells can be differentiated into liver progenitor cells and produce mature liver cells Liver transplantation is the mainstay of treatment for patients with end-stage liver disease, the 12th leading cause of death in the United States, but new research from the Icahn School of Medicine at Mount Sinai, published in the online journal Cell Stem Cell today, suggests that it may one day become possible to regenerate a liver using cell therapy in patients...

Research Shows How To Improve Stem Cells’ Cartilage Formation
2013-06-05 09:17:52

The University of Pennsylvania Cartilage injuries are difficult to repair. Current surgical options generally involve taking a piece from another part of the injured joint and patching over the damaged area, but this approach involves damaging healthy cartilage, and a person´s cartilage may still deteriorate with age. Bioengineers are interested in finding innovative ways to grow new cartilage from a patient´s own stem cells, and, thanks to a new study from the University of...

Stem Cells And New Drug Could Reverse Type 1 Diabetes
2013-05-30 04:49:45

redOrbit Staff & Wire Reports - Your Universe Online Damage caused to insulin-producing cells by the immune systems of type 1 diabetes patients could be more damaging than previously believed, but a University of Missouri scientist believes that their new discovery could lead to the development of a potential cure for the condition. Individuals suffering from type 1 diabetes rely upon their daily insulin injections in order to survive, and without those shots their body´s...

2013-05-29 08:30:18

BRT to Launch "brtx-C Cosmetic" Program JUPITER, Fla., May 29, 2013 /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: BRTX), a life sciences company focused on developing stem cell based cellular therapies for various personal medical applications, today announced that it has developed a human cellular-derived extract that, per initial in vitro studies, when applied to skin cells, appears to cause a significant increase in collagen and fibronectin...

2013-05-28 21:33:18

Transplantation of human stem cells in an experiment conducted at the University of Wisconsin-Madison improved survival and muscle function in rats used to model ALS, a nerve disease that destroys nerve control of muscles, causing death by respiratory failure. ALS (amyotrophic lateral sclerosis) is sometimes called "Lou Gehrig's disease." According to the ALS Association, the condition strikes about 5,600 Americans each year. Only about half of patients are alive three years after...

2013-05-27 23:14:27

Study into effect of adult stem cells on disease continues. Tijuana, Mexico (PRWEB) May 27, 2013 Regenerative Medicine Institute, Mexico (RMI) recently hit the three year milestone in its clinical research trial of adult stem cells. The trial seeks to discover the impact of stem cells on degenerative conditions such as heart disease, COPD, vascular issues, orthopedic conditions, and other chronic health problems. Regenerative Medicine is an institute of board certified, multi-specialty...

2013-05-21 08:28:20

Presentation to be Webcast at 2:30 Eastern Time on May 30, 2013 JUPITER, Fla., May 21, 2013 /PRNewswire/ -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: BRTX), a life sciences company focused on developing stem cell based therapies for various personal applications, announced that Mark Weinreb, its President and CEO, will be presenting at the Marcum MicroCap Conference. The conference will be held on Thursday, May 30, 2013 at the Grand Hyatt Hotel, located at...

2013-05-20 23:04:44

Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research and development, announced today that Robert L. Wilensky, MD, Professor of Medicine and Director of Interventional Cardiology Research at the University of Pennsylvania has agreed to join the Scientific and Medical Advisory Board for Stemedica´s Cardiology Division. San Diego, CA (PRWEB) May 20, 2013 Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing,...

2013-05-20 08:27:38

SEOUL, South Korea, May 20, 2013 /PRNewswire/ -- RNL BIO Co. Ltd., a stem cell biotechnology company dedicated to the commercialization of autologous cell therapy products for a variety of degenerative, ischemic and other indications, announces the availability of adult stem cell banking in the United States beginning on June 20, 2013. RNL BIO previously offered these services through another company, but will now provide the latest, safest technologies directly. As the sole global provider...